KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Opko Health (OPK) over the last 14 years, with Q3 2025 value amounting to $18.3 million.

  • Opko Health's Deferred Taxes rose 5023.83% to $18.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 158370.79%. This contributed to the annual value of $21.5 million for FY2024, which is 1465068.49% up from last year.
  • Opko Health's Deferred Taxes amounted to $18.3 million in Q3 2025, which was up 5023.83% from -$15.7 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Deferred Taxes ranged from a high of $18.3 million in Q3 2025 and a low of -$39.9 million during Q3 2022
  • For the 5-year period, Opko Health's Deferred Taxes averaged around -$2.5 million, with its median value being -$101000.0 (2021).
  • Its Deferred Taxes has fluctuated over the past 5 years, first skyrocketed by 74626.51% in 2021, then tumbled by 3944554.46% in 2022.
  • Opko Health's Deferred Taxes (Quarter) stood at $8.5 million in 2021, then tumbled by 399.45% to -$25.5 million in 2022, then skyrocketed by 71.94% to -$7.2 million in 2023, then surged by 293.28% to $13.8 million in 2024, then skyrocketed by 32.12% to $18.3 million in 2025.
  • Its last three reported values are $18.3 million in Q3 2025, -$15.7 million for Q2 2025, and -$7.4 million during Q1 2025.